Stock Ticker

  • Loading stock data...

DYAI’s C1 Technology May be Key in the Race to Vaccine-Induced Herd Immunity

Dyadic International Inc (NASDAQ:DYAI) is in an interesting position, being one of the very few names in the anti-Covid space that offer a new path that isn’t simply a reproduction or tie-in to the big pharma game right now. DYAI has a new approach that isn’t new-age quote-unquote “science”, but a powerful new potential solution […]

Spotlight: Progressive Care Inc (OTCMKTS:RXMD) Ramps Up Covid-19 Vaccinations (AZN, MRNA, NVAX, PFE, CVS, WBA, RAD)

The vaccine is now a defining part of the world economy, with Evercore analysts predicting the first round of vaccinations (ie, those taking place this year before adjustments to new variants) will add up to about $140 billion in sales in the US. Stocks related to this theme make up a high interest group that […]

DYAI in Focus: Upstart Vaccine Maker Says has Faster Way to Vaccinate the World (AZN, MRNA, NVAX, PFE, JNJ, BNTX)

Imagine 100 people gathered in a large room. Now imagine that some of them have symptomatic Covid-19. Not a great situation. But now imagine that you had a magic instant-effect vaccine pill machine in the room. As you start to hand out the pills, you can sense the feel of the room starting to loosen […]

Stocks for the Pandemic Long Haul (FLGT, ALST, HOLX)

Scientists are beginning to arrive at the notion that the fight with Covid-19 is not a short raging battle that will be over by summer 2021 but a long-term war that will be waged for many years to come, with a constant need for PPE, testing, vaccine rejiggering, specialized air filtration solutions, and other ‘coping’ […]

Virus Testing Stocks Heat Up (HOLX, ALST, PKI)

While vaccines are on the way and case numbers have started to move in the right direction, signaling the waning of the pandemic crisis, COVID-19 isn’t going anywhere. Unfortunately, it will be with us in some form for quite some time. While we can potentially get fatalities down to under the seasonal flu over time, […]

Three Stocks for the Battle Ahead (LLY, RXMD, LH)

Eventually, there will be a vaccine.  But, according to the WHO leadership even yesterday, confidence is waning in a “silver bullet” pharma solution for COVID-19. We may be in “coping” mode for quite some time yet.  For investors, that means an increased focus on testing, PPE, and remote process management.  With that in mind, we […]

Virus Protection as an Investment Opportunity (CLX, HON, BLGO, MMM)

As we start to gain more ground in our collective battle against the COVID-19 pandemic, the role of personal protection equipment and supplies looms large as a major concept for investors active with capital and willing to mobilize that capital toward companies able to make a difference while delivering value to their shareholders. While we […]